Your browser doesn't support javascript.
loading
Pregnancy outcomes and risk of endometrial cancer: A pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium.
Jordan, Susan J; Na, Renhua; Weiderpass, Elisabete; Adami, Hans-Olov; Anderson, Kristin E; van den Brandt, Piet A; Brinton, Louise A; Chen, Chu; Cook, Linda S; Doherty, Jennifer A; Du, Mengmeng; Friedenreich, Christine M; Gierach, Gretchen L; Goodman, Marc T; Krogh, Vittorio; Levi, Fabio; Lu, Lingeng; Miller, Anthony B; McCann, Susan E; Moysich, Kirsten B; Negri, Eva; Olson, Sara H; Petruzella, Stacey; Palmer, Julie R; Parazzini, Fabio; Pike, Malcolm C; Prizment, Anna E; Rebbeck, Timothy R; Reynolds, Peggy; Ricceri, Fulvio; Risch, Harvey A; Rohan, Thomas E; Sacerdote, Carlotta; Schouten, Leo J; Serraino, Diego; Setiawan, Veronica W; Shu, Xiao-Ou; Sponholtz, Todd R; Spurdle, Amanda B; Stolzenberg-Solomon, Rachael Z; Trabert, Britton; Wentzensen, Nicolas; Wilkens, Lynne R; Wise, Lauren A; Yu, Herbert; La Vecchia, Carlo; De Vivo, Immaculata; Xu, Wanghong; Zeleniuch-Jacquotte, Anne; Webb, Penelope M.
Afiliação
  • Jordan SJ; Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Na R; School of Public Health, University of Queensland, Brisbane, Queensland, Australia.
  • Weiderpass E; Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Adami HO; Director's Office, International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Anderson KE; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • van den Brandt PA; Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Oslo, Norway.
  • Brinton LA; School of Public Health, Division of Epidemiology & Community Health, University of Minnesota, Minneapolis, Minnesota, USA.
  • Chen C; Screening, Prevention, Etiology and Cancer Survivorship Program, University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA.
  • Cook LS; Department of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
  • Doherty JA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
  • Du M; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Friedenreich CM; Division of Epidemiology, Biostatistics & Preventive Medicine, Department of Internal Medicine, NM Health Sciences Center, University of New Mexico, University of New Mexico, Albuquerque, New Mexico, USA.
  • Gierach GL; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Goodman MT; Department of Population Health Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
  • Krogh V; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Levi F; Department of Cancer Epidemiology and Prevention Research, Cancer Care Alberta, Alberta Health Services, Calgary, Alberta, Canada.
  • Lu L; Departments of Oncology and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Miller AB; Integrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
  • McCann SE; Cancer Prevention and Control Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Moysich KB; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Negri E; Department of Epidemiology and Health Services Research, Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
  • Olson SH; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.
  • Petruzella S; Epidemiology Division, Dalla Lana School of Public Health, Toronto, Ontario, Canada.
  • Palmer JR; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
  • Parazzini F; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
  • Pike MC; Department of Biomedical and Clinical Sciences, Università degli Studi di Milano, Milan, Italy.
  • Prizment AE; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Rebbeck TR; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Reynolds P; Slone Epidemiology Center at Boston University, Boston, Massachusetts, USA.
  • Ricceri F; Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
  • Risch HA; Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
  • Rohan TE; Department of Obstetrics and Gynaecology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Sacerdote C; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Schouten LJ; Screening, Prevention, Etiology and Cancer Survivorship Program, University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA.
  • Serraino D; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA.
  • Setiawan VW; Division of Population Science, Dana-Farber Cancer Institute and Harvard TH Chan School of Public Health, Boston, Massachusetts, USA.
  • Shu XO; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
  • Sponholtz TR; Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy.
  • Spurdle AB; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.
  • Stolzenberg-Solomon RZ; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Trabert B; Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.
  • Wentzensen N; Department of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
  • Wilkens LR; Cancer Epidemiology Unit, Centro di Riferimento Oncologico IRCCS, Aviano, Italy.
  • Wise LA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Yu H; Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • La Vecchia C; Slone Epidemiology Center at Boston University, Boston, Massachusetts, USA.
  • De Vivo I; Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
  • Xu W; Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Zeleniuch-Jacquotte A; Genetics and Computational Biology Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Webb PM; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Int J Cancer ; 148(9): 2068-2078, 2021 05 01.
Article em En | MEDLINE | ID: mdl-33105052
ABSTRACT
A full-term pregnancy is associated with reduced endometrial cancer risk; however, whether the effect of additional pregnancies is independent of age at last pregnancy is unknown. The associations between other pregnancy-related factors and endometrial cancer risk are less clear. We pooled individual participant data from 11 cohort and 19 case-control studies participating in the Epidemiology of Endometrial Cancer Consortium (E2C2) including 16 986 women with endometrial cancer and 39 538 control women. We used one- and two-stage meta-analytic approaches to estimate pooled odds ratios (ORs) for the association between exposures and endometrial cancer risk. Ever having a full-term pregnancy was associated with a 41% reduction in risk of endometrial cancer compared to never having a full-term pregnancy (OR = 0.59, 95% confidence interval [CI] 0.56-0.63). The risk reduction appeared the greatest for the first full-term pregnancy (OR = 0.78, 95% CI 0.72-0.84), with a further ~15% reduction per pregnancy up to eight pregnancies (OR = 0.20, 95% CI 0.14-0.28) that was independent of age at last full-term pregnancy. Incomplete pregnancy was also associated with decreased endometrial cancer risk (7%-9% reduction per pregnancy). Twin births appeared to have the same effect as singleton pregnancies. Our pooled analysis shows that, while the magnitude of the risk reduction is greater for a full-term pregnancy than an incomplete pregnancy, each additional pregnancy is associated with further reduction in endometrial cancer risk, independent of age at last full-term pregnancy. These results suggest that the very high progesterone level in the last trimester of pregnancy is not the sole explanation for the protective effect of pregnancy.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias do Endométrio Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Int J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias do Endométrio Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Int J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália